logo

CNTB

Connect BiopharmaยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

CNTB fundamentals

Connect Biopharma (CNTB) released its earnings on Nov 12, 2025: revenue was 16.00K (YoY -98.69%), beat estimates; EPS was -0.31 (YoY -34.78%), missed estimates.
Revenue / YoY
16.00K
-98.69%
EPS / YoY
-0.31
-34.78%
Report date
Nov 12, 2025
EPS
Revenue

Revenue & Expenses

CNTB has released its 2025 Q3 earnings report, with revenue of 16.00K, reflecting a YoY change of -98.69%, and net profit of -17.20M, showing a YoY change of -33.58%. The Sankey diagram below clearly presents CNTB's revenue sources and cost distribution.

Key Indicators

Connect Biopharma (CNTB) key financial stats and ratios, covering profitability, financial health, and leverage.
Connect Biopharma (CNTB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Connect Biopharma (CNTB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Connect Biopharma (CNTB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Connect Biopharma (CNTB) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Connect Biopharma (CNTB) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield